Track topics on Twitter Track topics that are important to you
The Scandinavian country of Sweden is home to a thriving biotechnology industry, one of the top 5 in Europe. Europe has become a global center for the industry, helped by €2 billion worth of fu...
Eligard® is a hormone compound for the treatment of advanced, hormone-dependent prostate cancer. The active ingredient (leuprolide acetate) significantly reduces the level of the male sex hormon...
AA amyloidosis affects approximately 35,000 - 50,000 individuals in the United States, Europe (Top 5 countries) and Japan. The disease occurs in a subset of patients with long-lasting inflammatory c...
At OncoDNA, our philosophy is to provide the most suitable test in terms of rapidity and cost. That’s why we follow a 3 tier approach to find tumour mutations which can respond to new cancer t...
Phoenix MarCom is a specialist marketing communications company, working with clients in the clean tech (including renewables, environmental technology, low carbon and sustainability), scientific an...
The US FDA has told Wockhardt its quality issues are company-wide, citing problems at subsidiary Morton Grove as an example in a warning letter published today.
* Says it signed contract with Wockhardt Bio AG, Switzerland, for a blood pressure lowering generic drug product
Wockhardt on Wednesday revealed that it had received another US Food and Drug Administration warning…
Wockhardt claims the US has approved its version of the combination antibiotic Zosyn (piperacillin and tazobactam).
Irish regulators have recommended Wockhardt’s injectable drug plant in Shendra, Aurangabad have its GMP certificate renewed just a month after the US FDA criticized the same site.
Wockhardt says Irish regulators have recommended renewal of its Shendra, Aurangabad facility's GMP certificate.
A Wockhardt facility in India put under import alert last year has received a US FDA warning letter citing issues ranging from data discrepancies to inappropriate aseptic clothing.
Fresenius Kabi wants Wockhardt to change a BSE filing it says does not accurately reflect its role in the production of a Zosyn generic recently approved in the US.
The veterinary future in Europe was discussed at the general assembly of the Federation of Veterinarians of Europe in November. Following in the footsteps of the BVA/RCVS Vet Futures project, a simila...
The high mortality among HIV/tuberculosis (TB) coinfected patients in Eastern Europe is partly explained by the high prevalence of drug-resistant TB. It remains unclear whether outcomes of HIV/TB pati...
Corrigendum to "EuReCa ONE-27 Nations, ONE Europe, ONE Registry A prospective one month analysis of out-of-hospital cardiac arrest outcomes in 27 countries in Europe" Resuscitation 105 (2016) 188-195.
The proportion of females among neurosurgeons appears to be growing worldwide with time. Official data concerning the current situation across Europe have not yet been published. Thus, there are still...
The Cardiovascular and Interventional Radiological Society of Europe (CIRSE) prompted an initiative to frame the current European status of anesthetic practices for interventional radiology, in consid...